Therapeutic Advances in Drug Safety

Papers
(The median citation count of Therapeutic Advances in Drug Safety is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Impact of different doses of esketamine on the incidence of hypotension in propofol-based sedation for colonoscopy: a randomized controlled trial34
Age-stratified analysis of adverse event signals for clarithromycin: a disproportionality analysis using the FDA Adverse Event Reporting System31
Safety of dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials26
Drug interactions in patients with alcohol use disorder: results from a real-world study on an addiction-specific ward22
HIV/AIDS patients’ knowledge, attitude, and practice toward anti-retroviral therapy medications’ adverse effects and associated factors in Tikur Anbessa Specialized Hospital17
Effect of heparin for the prevention of venous thromboembolism in patients with spontaneous intracranial cerebral hemorrhage: a meta-analysis14
Inappropriate quetiapine use at a large academic medical center: frequency of misuse and associated costs of adverse effects12
Patients’ views on Self-administration of Medication during hospitalisation: a mixed-methods study12
Development and psychometric assessment of self-reported patient medication safety scale (SR-PMSS)12
Ten-year trends in adverse drug reaction–related hospitalizations among people with dementia11
A disproportionality analysis for assessing the safety of FLT3 inhibitors using the FDA Adverse Event Reporting System (FAERS)11
Interventions and impact of pharmacist-delivered services in perioperative setting on clinically important outcomes: a systematic review and meta-analysis11
Adverse event profiles of CDK4/6 inhibitors: data mining and disproportionality analysis of the FDA adverse event reporting system11
Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge10
Determinants of COVID-19 vaccine-induced myocarditis10
Could chlorophyllins improve the safety profile of beta-d-N4-hydroxycytidine versus N-hydroxycytidine, the active ingredient of the SARS-CoV-2 antiviral molnupiravir?10
The 7th European Pharmacovigilance Congress: speaker abstracts8
Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study8
Flow rate accuracy of infusion devices within healthcare settings: a systematic review8
Association between number of medications and indicators of potentially inappropriate polypharmacy: a population-based cohort of older adults in Quebec, Canada7
Development and validation of a risk-prediction model for adverse drug reactions in real-world cancer patients treated with anlotinib7
Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature6
Definition of self-medication: a scoping review6
Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community5
Safety of triazole antifungals: a pharmacovigilance study from 2004 to 2021 based on FAERS5
Governance of artificial intelligence and machine learning in pharmacovigilance: what works today and what more is needed?4
Effect of a closed-loop medication order executive system on safe medication administration at a tertiary hospital: a quasi-experimental study4
Determining the optimum dose of remifentanil in combination with propofol for total intravenous anaesthesia in hysteroscopy under Narcotrend and SPI monitoring4
Association of thrombopoietin-related drugs with thromboembolic events: Mendelian randomization and a real-world study4
Physiologically based pharmacokinetic modeling to predict the effect of risperidone on aripiprazole pharmacokinetics in subjects with different CYP2D6 genotypes and individuals with hepatic impairment4
Physiologically based pharmacokinetic modeling of candesartan to predict the exposure in hepatic and renal impairment and elderly populations4
Enhancing self-medication practices in the era of infodemic: the role of pharmacovigilance4
Acceptability of a cross-sectoral hospital pharmacist intervention for patients in transition between hospital and general practice: a mixed methods study4
Medication errors by caregivers in the homes of children discharged from a pediatric department in Ghana4
Adverse drug events associated with capecitabine: a real-world pharmacovigilance study based on the FAERS database4
The 6th European Pharmacovigilance Congress: speaker abstracts3
Oxaliplatin-associated shock in stage III colorectal cancer patients: real-world evidence in Taiwan3
Developing and piloting a cross-sectoral hospital pharmacist intervention for patients in transition between hospital and general practice3
Enhancing pharmacovigilance for robust drug safety monitoring: addressing underreporting and collaborative solutions3
Investigating the impact of a pharmacist intervention on inappropriate prescribing practices at hospital admission and discharge in older patients: a secondary outcome analysis from a randomized contr3
Assessing potential risk factors for metamizole-induced leukopenia2
An integrative systematic review of nurses’ involvement in medication deprescription in long-term healthcare settings for older people2
Harmonization of individual case safety reports transmission requirements among PAHO reference authorities: a review of their current regulation2
A retrospective pharmacovigilance study of post-marketing safety concerns with cefuroxime2
A post-marketing disproportionality analysis of the safety of ribociclib based on the FDA Adverse Event Reporting System2
Drug–drug interaction between tacrolimus and caspofungin in Chinese kidney transplant patients with different CYP3A5 genotypes2
Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database2
Anticholinergic burden among in-patients: a cross-sectional study on prevalence, determinants, and impact on mortality in Ethiopia2
Understanding, readiness, and response of healthcare professionals in combating falsified medical products in Eritrea: a population-based survey1
Impact of dipeptidyl peptidase-4 inhibitors on incidence of colorectal cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis1
Development and validation of a risk prediction model for linezolid-induced anemia in elderly patients: a retrospective cohort study1
Olanzapine for the prevention of postoperative nausea and vomiting after gynecologic laparoscopic surgery: a randomized controlled trial1
Navigating pharmacokinetic and pharmacodynamics challenges of β-lactam antibiotics in patients with low body weight: efficacy, toxicity, and dosage optimization1
The 90% effective dose of ciprofol and propofol with S-ketamine for painless abortion: a randomized, double-blind, sequential dose-finding trial1
Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 20211
Characterizing medication safety incidents in surgical patients: a retrospective cross-sectional analysis of incident reports1
The response to the COVID-19 pandemic trusted in pharmacovigilance to diminish communication risk1
Therapeutic drug monitoring and safety evaluation of voriconazole in the treatment of pulmonary fungal diseases1
Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customers1
Motivating deprescribing conversations for patients with Alzheimer’s disease and related dementias: a descriptive study1
The 5th European pharmacovigilance congress: speaker abstracts1
Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study1
Neurodevelopmental outcomes in children exposed prenatally to levetiracetam1
The crucial role of pharmacovigilance in managing infectious diseases in lower and middle-income countries1
Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score–matched analysis of real-world data1
Characterization of children’s prospective prescription review and exploration of factors influencing the success of interventions1
Prevalence and global trends of polypharmacy among people living with HIV: a systematic review and meta-analysis1
A critical opinion-based review of hospital pharmacy compounding with respect to the risk of leachable substances due to the off-label use of plastic primary packaging1
Direct oral anticoagulant use in hospitalized patients with atrial fibrillation across body mass index categories: design and rationale for a retrospective cohort study1
Short-term prognosis of polypharmacy in elderly patients treated in emergency departments: results from the EDEN project1
Joint use of population pharmacokinetics and machine learning for optimizing antiepileptic treatment in pediatric population1
Use of an electronic medication management support system in patients with polypharmacy in general practice: study protocol of a quantitative process evaluation of the AdAM trial1
0.13838291168213